Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01424722 · ClinicalTrials.gov registry record · NA
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
A NA study, sponsored by Abbott Medical Devices.
- Terminated
- Registry status
- NA
- Development phase
- 2,258
- Enrollment target
NCT01424722 is a NA study that was terminated before completion, run by Abbott Medical Devices. The registered enrollment target is 2,258 participants.
The verdict
NCT01424722, a NA study, was terminated before completion, sponsored by Abbott Medical Devices.
- TERMINATED
- Registry status
- NA
- Development phase
- 2,258 participants
- Enrollment target
Study Summary
This is a prospective, non-randomized, multicenter, pivotal Investigational Device Exemption (IDE) study. The intent of this study is to demonstrate the safety and effectiveness of the ST Monitoring Feature in St Jude Medical ICD systems.
Interventions
- DEVICE Fortify® ST, Fortify Assura® ST, Ellipse® ST family of devices
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,258 participants |
| Start Date | 2011-08 |
| Est. Completion | 2017-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01424722
The ClinicalTrials.gov registry entry for NCT01424722 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2,258 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fortify® ST, Fortify Assura® ST, Ellipse® ST family of devices is the first listed.
NCT01424722 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01424722 about?
NCT01424722 is a clinical study titled "ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients". This is a prospective, non-randomized, multicenter, pivotal Investigational Device Exemption (IDE) study. The intent of this study is to demonstrate the safety and effectiveness of the ST Monitoring Feature in St Jude Medical ICD systems.
What is the current status of trial NCT01424722?
This trial is currently terminated. It is a NA study. The enrollment target is 2,258 participants. The study started on 2011-08. Estimated completion is 2017-06.
What interventions are being tested in trial NCT01424722?
The interventions under investigation include: Fortify® ST, Fortify Assura® ST, Ellipse® ST family of devices (DEVICE).
Who is sponsoring clinical trial NCT01424722?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.